Haemostatic markers have been implicated in the development and progression of vascular disease. We investigated the associations of several haemostatic markers (fibrinogen, D-dimer, FV, FVII, FVIII, von Willebrand factor (vWF) and antithrombin III) with two quantitative measures of vascular disease in adults with hypertension. Participants included 1051 African Americans (65 ± 9 years, 72% women) and 894 non-Hispanic whites (61 ± 9 years, 55% women) belonging to hypertensive sibships. Phenotypes of vascular disease included the ankle-brachial index (ABI), a measure of peripheral arterial disease, and urinary albumin/creatinine ratio (UACR), a surrogate of glomerular endothelial function. Generalized estimating equations were used to assess whether plasma levels of haemostatic markers were associated with measures of arteriosclerosis, after adjustment for conventional risk factors and medication (statin, aspirin and oestrogen) use. Higher fibrinogen and D-dimer were significantly associated with lower ABI in African Americans (Po0.001 and 0.004 respectively) and in non-Hispanic whites (Po0.001 and 0.010 respectively). Higher fibrinogen (Po0.001), D-dimer (P ¼ 0.003), FVIII (Po0.001) and vWF (Po0.001) were significantly associated with higher UACR in African Americans, whereas, in non-Hispanic whites, higher fibrinogen (P ¼ 0.020) and FVII (P ¼ 0.006) were significantly associated with higher UACR. Our findings indicate that in adults with essential hypertension, several markers in the haemostatic pathway are independently associated with ABI and UACR, two measures of vascular disease.
Introduction
Hypertension is a major risk factor for arteriosclerosis, that is atherosclerosis, affecting large and medium-sized vessels and arteriolosclerosis affecting the microvasculature. Target organ damage from hypertension is caused by ischaemia, either from obstructive atherosclerosis that impedes blood flow or from arteriolosclerosis that chronically impairs perfusion within target organs. Although arteriosclerosis in hypertensive adults is accelerated in the presence of vascular risk factors such as age and diabetes, much of the inter-individual variation in measures of arteriosclerosis cannot be explained based on known risk factors, and new biomarkers in aetiologic pathway of arteriosclerotic vascular disease may explain some of the remaining variability. Identification of new biomarkers will provide insight into underlying pathophysiologic mechanisms and facilitate development of novel diagnostic and therapeutic approaches to retard arteriosclerotic vascular disease and thereby prevent target organ damage, a major cause of morbidity and mortality in hypertension.
Hypertensive adults appear to have an activated coagulation system and decreased fibrinolytic capacity compared to normotensive adults. [1] [2] [3] [4] For example, hypertensive adults have higher circulatory levels of fibrinogen, 5 FVII, 5 FVIII, 5 von Willebrand factor (vWF) 6 and plasminogen activator inhibitor type 1 7, 8 than normotensive adults. Whether increased levels of haemostatic markers are associated with target organ damage in the setting of hypertension is not fully elucidated. In this study, we hypothesized that haemostatic markers contribute to both atherosclerosis ('macrovascular' disease) of peripheral arteries as well as arteriolosclerosis ('microvascular' disease) in the renal vascular bed.
We therefore examined the association of plasma levels of several haemostatic markers including fibrinogen, D-dimer, FV, FVII, FVIII, vWF and antithrombin III (AT III) with the ankle-brachial index (ABI), a measure of peripheral arterial disease (PAD) and urinary albumin/creatinine ratio (UACR), a surrogate of glomerular endothelial function.
Materials and methods
Participants belonged to the Genetic Epidemiology Network of Arteriopathy study, a multicentre, community-based study that aims to identify genetic variants influencing blood pressure (BP) levels and the development of target organ damage due to hypertension. 9 The study was approved by the institutional review boards of the University of Mississippi Medical Center, Jackson, MS and Mayo Clinic, Rochester, MN, USA. Written informed consent was obtained from each participant. Recruitment and participants characteristics in the initial phase of this study have been previously described. 10 The present study was limited to 1945 participants (1051 African Americans and 894 non-Hispanic whites) who had hypertension. We excluded 59 participants who were on coumadin.
Height was measured by stadiometer, weight by electronic balance and body mass index (BMI) was calculated as weight in kilograms divided by the square of height in metres. Resting systolic BP (SBP) and diastolic BP were measured in the supine position by random zero sphygmomanometer. The diagnosis of hypertension was established based on BP levels measured at the study visit (X140/ 90 mm Hg) or a prior diagnosis of hypertension and current treatment with antihypertensive medications. Diabetes was considered present if the subject was being treated with insulin or oral agents or had a fasting glucose level X126 mg/100 ml. 'Ever' smoking was defined as having smoked more than 100 cigarettes. Information about the use of BP medications and statins was obtained from the participants at the time of the study visit. Blood was drawn by venipuncture after an overnight fast. Serum total cholesterol and high-density lipoprotein (HDL) cholesterol were measured by standard enzymatic methods.
Haemostatic markers
Haemostatic markers were measured in citrated plasma. Fibrinogen was measured by the Clauss (clotting time based) method.
11 vWF was measured by solid-phase sandwich enzyme-linked immunosorbent assay kit (Diagnostica Stago, Asnieres, France). The remaining markers were measured on an STA Compact instrument (Diagnostica Stago). Levels of FV, FVII and FVIII were measured by clotbased assays using STA-Neoplastine CI Plus and STA reagents, D-dimer was measured by immunoturbidimetry using STA-Liatest reagents and AT III was measured by chromogenic methods using STAStachrom AT-III reagents. Inter-assay coefficients of variance were: fibrinogen, 2.5-3.5%; FV, 4.7-6.5%; FVII, 4.1-4.4%; FVIII, 4.7-6.5%; vWF, 4.5-9.5%; D-dimer, 3.1-24.4%; AT III, 3.8-3.9%.
Ankle-brachial index
At each centre, the ABI was measured by examiners who had undergone training in Mayo Clinic's noninvasive vascular laboratory in Rochester. An identical, standardized protocol was used at both centres. Following a 5-min rest, subjects were evaluated in the supine position. Appropriately sized BP cuffs were placed on each arm and ankle, and a Doppler ultrasonic instrument (Medisonics, Minneapolis, MN, USA) was used to detect arterial signals. The cuff was inflated to 10 mm Hg above SBP and deflated at 2 mm Hg s À1 . The first reappearance of the arterial signal was taken as the SBP. To calculate the ABI, the SBP at each ankle site (posterior tibial and dorsalis pedis arteries) was divided by the higher of the two brachial pressures. The lower of the average ABIs from the two legs was used in the analyses. The Doppler method we used is reproducible with the coefficient of repeatability ranging from 0.10 to 0.13 and intra-class correlation coefficient ranging from 0.81 to 0.85 for different modes of ABI calculation. 12 Subjects with ABI 41.3 (n ¼ 142) were excluded from the analyses as they may have non-compressible arteries due to medial arterial calcification. 13 An ABI o0.9 was used to indicate the presence of PAD.
Urinary albumin/creatinine ratio Albuminuria was assessed by UACR. The first voided urine was collected on the morning of the study visit and stored at -80 1C until analyzed. Urine albumin, urine creatinine and serum creatinine concentrations were measured by standard methods on a Hitachi 911 Clinical Chemistry Analyzer (Roche Diagnostics), and UACR was expressed as milligrams of albumin per gram of creatinine. Subjects with creatinine 42.5 mg/100 ml (n ¼ 9) or UACR 43000 mg g À1 (n ¼ 6) were excluded from the analyses.
Statistical methods
Continuous data were summarized as either mean ± s.d. or median and quartiles and categorical data were expressed as percentages. Owing to significant differences in age and the proportion of women in the two ethnic groups, differences in characteristics between the two ethnic groups were assessed after adjustment for age and sex. Analyses to identify haemostatic markers independently associated with ABI and UACR were performed separately in each ethnic group. Plasma triglycerides, D-dimer, vWF and UACR were log-transformed to reduce skew-ness. In each ethnic group, pair-wise correlations between fibrinogen, D-dimer, FV, FVII, FVIII, vWF and AT III were assessed by Pearson's correlation coefficients.
In each ethnic group, we constructed multiple regression models including age, sex, waist circumference (as a measure of adiposity), history of smoking, diabetes, hypertension, total cholesterol, HDL cholesterol, medication (statin, aspirin, oestrogen) use and previous history of myocardial infarction (MI) or stroke and performed backward elimination to identify variables independently associated with each measure of arteriosclerosis. We then constructed multivariable linear models that adjusted for conventional risk factors and other potential confounding variables to identify haemostatic markers independently associated with each phenotype of arteriosclerosis. Age and sex were forced into all multivariable regression models.
We also tested for interactions between conventional risk factors and haemostatic markers in the prediction of vascular disease phenotypes and incorporated interactions significant at Po0.01 in the models. The proportion of variance (R 2 ) in the measure of vascular disease explained by a haemostatic marker in multivariable regression models was estimated using a likelihood ratio test statistic. 14 We calculated the percentage increase in R 2 after adding a haemostatic marker to the model that included conventional risk factors and medication use. Because of the presence of sibships in the sample, regression analyses were performed using generalized estimating equations (GEE). 15 A two-sided P-value of o0.05 was used for statistical significance. Statistical analyses were carried out using SAS version 9.1 (SAS Institute, Cary, NC, USA) software package.
Results
African Americans were older and there was a greater proportion of women in both African American and non-Hispanic white cohorts (Table 1) . After adjustment for age and sex, African Americans had a higher prevalence of diabetes than their non-Hispanic white counterparts; lower use of statins, higher levels of fibrinogen, D-dimer, FV, FVIII, vWF and AT III, lower levels of FVII, lower ABI, higher prevalence of PAD and higher UACR than their nonHispanic white counterparts ( Table 2) . Correlations of r40.5 were observed between FVIII and vWF in both ethnic groups. The correlations between the remaining haemostatic markers were modest (ro0.3).
Ankle-brachial index
In African Americans, older age, higher total cholesterol, history of smoking, previous history of MI or stroke and diabetes were associated with lower ABI whereas greater waist circumference and higher HDL cholesterol were associated with higher ABI. In separate GEE models (one haemostatic marker added at a time), after adjustment for the conventional risk factors and medication use, higher fibrinogen (Po0.001) and D-dimer (P ¼ 0.004) were each significantly associated with lower ABI. Conventional risk factors and medication use explained 12.7% of the variance in ABI. Adding fibrinogen or D-dimer significantly increased the R 2 (fibrinogen: 16% relative increase and D-dimer: 10% relative increase). We observed a significant interaction (Po0.01) between fibrinogen and sex in the prediction of ABI, indicating that the association was stronger in men than in women (Figure 1a ). We also P-values are for ethnic differences after adjustment for age and sex.
Haemostatic markers and target organ damage in hypertensives M Khaleghi et al observed significant interactions (Po0.01) between D-dimer and age and between D-dimer and HDL cholesterol in the prediction of ABI. These interactions remained significant after adjustment for conventional risk factors (Table 3 ). The interactions indicated that the significant, inverse association between D-dimer and ABI was stronger as age increased or as HDL cholesterol decreased.
In non-Hispanic whites, older age, male sex, smoking and previous history of MI or stroke were associated with lower ABI and oestrogen use was associated with higher ABI. In separate GEE models (one haemostatic marker added at a time), after adjustment for conventional risk factors and medication use, higher fibrinogen (Po0.001) and Ddimer (P ¼ 0.010) were each significantly associated Haemostatic markers and target organ damage in hypertensives M Khaleghi et al with lower ABI. Conventional risk factors and medication use explained 11.5% of the variance in ABI. Adding fibrinogen or D-dimer significantly increased the R 2 (fibrinogen: 10% relative increase and D-dimer: 11% relative increase). As in African Americans, we observed significant interactions (Po0.01) between D-dimer and age and between D-dimer and HDL cholesterol in the prediction of ABI (Figures 1b and c) . In addition, a significant interaction was present between oestrogen use and D-dimer in non-Hispanic white women, indicating that the inverse association of D-dimer with ABI was present only among non-users (Figure 1d ).
Urinary albumin/creatinine ratio
In African Americans, higher SBP, diabetes, previous history of MI or stroke and higher plasma triglyceride levels were associated with higher UACR whereas oestrogen use was associated with lower UACR. In separate GEE models, after adjustment for the above-mentioned conventional risk factors and medication use, higher fibrinogen (Po0.001), D-dimer (P ¼ 0.003), FVIII (Po0.001) and vWF (Po0.001) were each significantly associated with higher UACR (Table 4) . Conventional risk factors and medication use explained 18.5% of the variance in UACR. Each of the haemostatic markers significantly associated with UACR increased the R 2 , the increase ranging from 4 to 12% (Table 4) .
In non-Hispanic whites, higher SBP, diabetes and previous history of MI or stroke were associated with higher UACR and oestrogen use was associated with lower UACR. In separate GEE models, after adjustment for above-mentioned conventional risk factors and medication use, higher fibrinogen (P ¼ 0.020) and FVII (P ¼ 0.006) were each significantly associated with higher UACR, whereas higher D-dimer (P ¼ 0.084), FV (P ¼ 0.078) and AT III (P ¼ 0.070) were each weakly associated with higher UACR (Table 4) . Conventional risk factors and medications use explained 7.8% of the variance in UACR. Each haemostatic marker significantly associated with UACR increased the R 2 , the increase ranging from 4 to 16% (Table 4) .
Discussion
The present study demonstrates that plasma levels of several markers in the haemostatic pathway are associated with measures of vascular disease in adults with essential hypertension, independent of conventional risk factors (Table 5 ). Higher fibrinogen and D-dimer were associated with lower ABI in both ethnic groups. Higher fibrinogen, D-dimer, FVIII and vWF were associated with higher UACR in African Americans, whereas in non-Hispanic whites, higher fibrinogen and FVII were associated with higher UACR. The haemostatic markers predicted a statistically significant albeit modest proportion of inter-individual variation in the ABI and UACR. Some of the associations were present in both ethnic groups, whereas others were unique to one of the ethnic groups. The associations were attenuated after adjustment for conventional risk factors, specifically after adjustment for age (analyses not shown), suggesting the risk due to conventional factors may be partially mediated by haemostatic markers or that the haemostatic markers were influenced by conventional risk factors. The strength of associations differed within a phenotype for different markers and across phenotypes for the same marker.
Ankle-brachial index
Fibrinogen and D-dimer were the only haemostatic markers independently associated with atherosclerotic burden as assessed by ABI. Both are biologically plausible markers for vascular disease. Fibrinogen, a soluble glycoprotein synthesized in the liver, participates in the two central processes of atherosclerosis, inflammation and thrombosis, and is a major determinant of blood viscosity. 16, 17 In addition, it stimulates smooth-muscle-cell migration and proliferation, promotes platelet aggregation and is also an acute-phase reactant. 18 The independent association between higher fibrinogen levels and lower ABI and greater prevalence of PAD have been reported by us and others.
19,20 D-dimer is formed by the degradation of cross-linked fibrin and is a marker of ongoing fibrinolysis associated with thrombosis and can induce the production of cytokines and thus indirectly stimulate the production of acute-phase proteins. 21 D-dimer levels have been persistently associated with presence and severity of PAD. 22, 23 Our findings extend the results of these studies by demonstrating a significant inverse association between levels of D-dimer and ABI in African Americans and non-Hispanic white adults with hypertension. Furthermore, we report that this association was modified by age and plasma HDL cholesterol levels. Higher levels of D-dimer seem to be a greater risk factor in older individuals and in patients with low HDL cholesterol (Figures 1b and c) .
Urinary albumin/creatinine ratio Both fibrinogen and D-dimer levels were significantly associated with UACR in the two ethnic groups, although in non-Hispanic whites the associations were weaker. These finding are consistent with a previous report that showed that the two markers were significantly associated with presence and severity of target organ damage assessed by World Health Organization criteria (based on creatinine clearance, proteinuria, ophthalmoscopy, electrocardiography, echocardiography and ultrasound examination of major arteries). 24 Barzilay et al. 25 have shown that higher levels of fibrinogen are 
Abbreviations: ABI, ankle-brachial index; UACR, urine albumin/ creatinine ratio; vWF, von Willebrand factor. +, Po0.05; ++, Po0.01; +++, Po0.001.
associated with the microalbuminuria in older adults (465 years) with hypertension. vWF and FVIII were significantly associated with UACR in African Americans. vWF is produced by megakaryocytes, platelets and vascular endothelial cells and mediates platelet aggregation and adhesion, and elevated levels may reflect endothelial dysfunction. 26 In addition, vWF carries FVIII in the circulation, and the levels of the two are significantly correlated. The associations of FVIII and vWF with UACR were significant in diabetic as well as non-diabetic patients (analyses not shown). Several studies have shown higher levels of vWF to be associated with microalbuminuria. 25, 27 Increased levels of vWF and FVIII may represent endothelial injury in renal arterioles that precedes the development of albuminuria. On the other hand, because both vWF and albumin excretion are associated with endothelial dysfunction, elevated level of vWF and albuminuria may develop concomitantly as a result of endothelial damage mediated by hypertension. FVII levels have been shown to be associated with higher urinary albumin excretion in elderly hypertensive adults, 28 and diabetic patients, 29, 30 consistent with our results in non-Hispanic whites. However, a study in older adults (465 years) did not find an association between FVII and microalbuminuria. 25 Therefore, current evidence does not clearly support the hypothesis that FVII is associated with urinary albumin excretion.
Hypertension is highly prevalent in African Americans and tends to be more severe and more often associated with target organ damage than in non-Hispanic whites. 31 Nearly 30% of the attributable risk of death in African Americans is due to hypertension, double that in non-Hispanic whites. 31 In the present study after adjustment for age and sex, African Americans had higher levels of haemostatic markers (except for FVII) consistent with previous reports, 32, 33 and greater severity of target organ damage than in non-Hispanic whites. Whether higher plasma levels of haemostatic markers contribute to greater susceptibility of African Americans to target organ damage mediated by hypertension cannot be addressed by this study and needs further investigation. Patients with higher levels of haemostatic markers may be at risk for target organ damage and may benefit from intensive risk factor modification to retard arteriosclerotic vascular damage. Whether lowering the levels of haemostatic markers such as fibrinogen and D-dimer in susceptible population groups by lifestyle/pharmacologic means is beneficial needs confirmation.
Strengths and limitations
The present study is the first to report an association between circulating levels of several haemostatic markers, such as fibrinogen, D-dimer, FVIII and vWF, with measures of vascular disease in hypertensive adults from two different ethnic groups, using uniform protocols including questionnaires, anthropometric and laboratory measurements. Limitations of this study include its cross-sectional nature. We cannot confirm whether higher haemostatic markers are causally related to the presence and severity of target organ damage, and with disease progression. 34 In addition, the markers were measured only once, and variation with time could not be taken into account. However, this would bias the result towards the null and underestimate the true associations. Multivariate regression may not fully adjust for the effect of risk factors such as diabetes that were prevalent in both ethnic groups and are known to promote target organ damage. We did not adjust the results for multiple testing, and some of the findings may have been due to chance. However, several associations were more than nominally significant and biologically plausible and therefore less likely to be due to chance. Fibrinogen, D-dimer and FVIII are all acute-phase reactants and the associations of these haemostatic markers with ABI and UACR could be due to chronic inflammation in vascular disease. When we adjusted the regression models for C-reactive protein these associations remained significant, suggesting a key function of haemostatic markers independent of systemic inflammation (analyses not shown).
